Goodwin Procter LLP has advised Fulcrum Therapeutics. Mintz has advised the underwriters. Fulcrum Therapeutics, Inc. (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company, has announced the pricing...
Fulcrum Therapeutics Prices $175 Million Public Offering of Stock and Pre-Funded Warrants
Terns Pharmaceuticals Completes $747.5 Million Public Offering of Common Stock
Wilmer Cutler Pickering Hale and Dorr has advised Terns Pharmaceuticals. Davis Polk has advised the representative of the underwriters. Terns Pharmaceuticals, Inc., a clinical-stage oncology company...
Wave Life Sciences Announces $402.5 Million Public Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, WongPartnership, and Choate Hall & Stewart have advised Wave Life Sciences. White & Case has advised the underwriters. Wave...
Immunovant Raises $550 Million in Common Stock Offering
Sidley Austin LLP has advised Immunovant, Inc. Latham & Watkins LLP has advised the underwriter. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on developing...
Lumexa Imaging Launches US$462.5 Million Initial Public Offering
Sidley has advised Lumexa Imaging Holdings, Inc. Ropes & Gray has represented the underwriters. Lumexa Imaging Holdings, Inc. has completed its initial public offering, issuing 25,000,000...
Belite Bio Prices $350 Million Public Offering of American Depositary Shares
O’Melveny & Myers LLP and Maples and Calder (Hong Kong) LLP have advised Belite Bio. Wilson Sonsini Goodrich & Rosati has advised Belite Bio on patent...
Cogent Biosciences Completes $345 Million Common Stock Offering and $200 Million Convertible Notes Offering
Gibson Dunn has represented Cogent Biosciences, Inc., Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for...
Eledon Pharmaceuticals Prices $50 Million Public Offering of Common Stock and Pre-Funded Warrants
O’Melveny & Myers LLP has advised Eledon Pharmaceuticals, Inc. Mintz has advised the underwriters. Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN), a clinical-stage biotechnology company, has announced the...
MoonLake Immunotherapeutics Completes $75 Million Follow-on Equity Offering
Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised Leerink Partners. MoonLake Immunotherapeutics has completed the pricing of an...
Benitec Biopharma Completes $100 Million Equity Offerings
Proskauer Rose LLP has advised Benitec Biopharma Inc. Mintz has advised the underwriters and placement agents. Benitec Biopharma Inc., a clinical-stage biotechnology company, has completed an...
Arcus Biosciences Completes $287.5 Million Common Stock Offering
Latham & Watkins has advised Arcus Biosciences. Gunderson Dettmer has advised the underwriters. Arcus Biosciences, a clinical-stage, global biopharmaceutical company listed on the NYSE under the...
Viridian Therapeutics Completes $289 Million Public Offering
Ropes & Gray LLP has advised Viridian Therapeutics, Inc., and WilmerHale has advised the underwriters. Viridian Therapeutics, Inc. has completed a public offering of 13,138,750 shares...